ANEXXA
Anexxa is a recruiting agency that offers job opportunities, training, and human resources solutions.
ANEXXA
Industry:
Employment Human Resources Recruiting Training
Founded:
2018-01-01
Address:
Porto, Lisboa, Portugal
Country:
Portugal
Website Url:
http://www.anexxa.pt
Total Employee:
501+
Status:
Active
Contact:
+351 223 261 887
Email Addresses:
[email protected]
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Apple Mobile Web Clips Icon Google Tag Manager Google Maps LetsEncrypt ReCAPTCHA Nginx Pound Sterling PHP
Similar Organizations
AUG Network
AUG Network is a human resources company that offers consulting, training, and staffing services.
Konnect Resources
Konnect Resources is a recruiting & staffing company that offers direct hires, training, employment and human resources services.
Swiss Interim
Swiss Interim is a recruiting agency that offers employment services, training, and advisory services.
Talent Xperts
Talent Xperts is a recruitment agency that offers HR solutions, recruitment, and training services.
Official Site Inspections
http://www.anexxa.pt Semrush global rank: 2.32 M Semrush visits lastest month: 8.41 K
- Host name: gesintegral.pt
- IP address: 94.46.180.225
- Location: Portugal
- Latitude: 38.7057
- Longitude: -9.1359
- Timezone: Europe/Lisbon
More informations about "Anexxa"
Anexxa - Crunchbase Company Profile & Funding
Organization. Anexxa . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. ... Contact Email [email protected]; Phone Number +351 223 261 887; Lists Featuring This Company. Edit Lists …See details»
Recursos Humanos - ANEXXA
A Anexxa é uma marca registada (INPI número: 672824), propriedade da Anexxa - Empresa de Trabalho Temporário, Lda, com Alvará 867/19. Objetivamos o crescimento em várias vertentes, Recrutamento & Seleção, Trabalho …See details»
Anexxa ® – Soluções de Recursos Humanos | LinkedIn
Anexxa ® – Soluções de Recursos Humanos | 7.461 seguidores no LinkedIn. Potenciamos a energia Humana! Aliamos os objetivos e estratégias dos negócios às necessidades e …See details»
ANEXXA - EMPRESA DE TRABALHO TEMPORÁRIO, LDA - Dun
Find company research, competitor information, contact details & financial data for ANEXXA - EMPRESA DE TRABALHO TEMPORÁRIO, LDA of PORTO, PORTO. Get the latest business …See details»
ANNEXa-I - Research Studies - PHRI - Population …
Jessica Vincent has more than 15 years’ experience in coordinating and managing large, international clinical trials. As Associate Program Manager, she oversees interventional trials, registries, and observational research studies in …See details»
Economic Evaluation of Andexanet Versus Prothrombin …
Mar 1, 2021 Graphical Abstract Background and Purpose: Andexanet was approved by the Food and Drug Administration in 2018 for reversal of life-threatening or uncontrolled bleeding associated with factor Xa anticoagulation; …See details»
Full Study Report of Andexanet Alfa for Bleeding …
Feb 7, 2019 Andexanet alfa is a modified recombinant inactive form of human factor Xa developed for reversal of factor Xa inhibitors. We evaluated 352 patients who had acute major bleeding within 18 hours afte...See details»
Evidence for Andexanet Alpha in Reversing …
May 10, 2021 In this issue of Stroke, Demchuk et al 14 report the results of a post hoc analysis of the ANNEXA-4 data specifically evaluating the hemostatic efficacy and antifactor Xa level reversal with andexanet alfa in 227 patients …See details»
Andexanet Alfa, Reversal Agent for Factor Xa Inhibitors, …
Jun 5, 2023 Andexanet alfa (Andexxa; AstraZeneca), compared with usual care, improves hemostasis in patients who have an intracranial bleed while taking a factor Xa inhibitor, according to top-line results of ANNEXA-I, a phase IV …See details»
Secondary Analyses of ANNEXA-I Trial Assessing …
Feb 28, 2024 The associate professor of neurology at McMaster University talked about findings from secondary analyses on the phase 4 ANNEXA-I trial assessing andexanet alfa in patients with acute intracerebral hemorrhage. …See details»
Final Study Report of Andexanet Alfa for Major Bleeding With …
Feb 20, 2023 Background: Andexanet alfa is a modified recombinant inactive factor Xa (FXa) designed to reverse FXa inhibitors. ANNEXA-4 (Andexanet Alfa, a Novel Antidote to the …See details»
Final ANNEXA-4 Results Published, Confirm Rapid Andexanet Alfa …
HONOLULU, HI—The final results of the ANNEXA-4 study contain no surprises, affirming that andexanet alfa (Andexxa; Portola Pharmaceuticals) quickly reverses the anticoagulant effects …See details»
ANNEXA-4: Andexanet Alfa and Factor Xa Inhibitors
Mar 4, 2019 EM Lit of Note: Disutility, thy Name is ANEXXA-4; The SGEM: Nothing Compares to You…Because There was no Comparison Group; Post Peer Reviewed By: Anand …See details»
Andexanet Alfa for Acute Major Bleeding Associated with Factor …
Sep 22, 2016 Andexanet alfa (andexanet) is a recombinant modified human factor Xa decoy protein that has been shown to reverse the inhibition of factor Xa in healthy volunteers. In this …See details»
Andexanet Alfa Should Be Used to Reverse Factor Xa Inhibitors in …
The ANEXXA-4 study was limited to a single arm; however, 322 patients from the ANEXXA-4 study were propensity matched to 88 patients receiving prothrombin complex concentrate from …See details»
ANNEXA-4 | ANDEXXA | For HCPs
Study design: ANNEXA-4 was a phase 3b/4, multicenter, prospective, single-arm, open-label study evaluating ANDEXXA in patients with acute major bleeding within 18 hours of FXa …See details»
Andexanet for Factor Xa Inhibitor–Associated Acute Intracerebral ...
May 15, 2024 We randomly assigned, in a 1:1 ratio, patients who had taken factor Xa inhibitors within 15 hours before having an acute intracerebral hemorrhage to receive andexanet or …See details»
ANNEXA-I – Andexanet for Factor Xa Inhibitor–Associated ICH
Jul 10, 2024 In a trial involving patients with ICH who had taken a factor Xa inhibitor within the previous 15 hours, andexanet rapidly reduced anti–factor Xa activity and resulted in better …See details»
The ANNEXA-A and ANNEXA-R Trials - The New England Journal …
Dec 17, 2015 Andexanet, a small-molecule factor Xa fragment, rapidly reversed the anticoagulant activity of rivaroxaban and apixaban in older healthy volunteers.See details»